Active specific immunotherapy of metastatic melanoma with an antiidiotype vaccine: a phase I/II trial of I-Mel-2 plus SAF-m.

Source:http://linkedlifedata.com/resource/pubmed/id/9164224

Download in:

View as

General Info

PMID
9164224